Genome Research and Personalized Medicine in Breast Cancer

Dear Colleagues,

Despite improved outcomes due to advanced systemic and targeted treatments, many breast cancer patients experience cancer relapse or drug-induced toxicities. Treatment-refractory outcomes result from intrinsic tumor biology, treatment-induced resistance traits, as well as host factors such as impaired drug metabolism and endogenous ligands interfering with drug–target action. Personalized treatment that utilizes precise patient selection and/or multimodal target approaches holds promise to mitigate clinical resistance to therapy.

This Special Issue of the Journal of Personalized Medicine aims to highlight the role of personalized medicine in both early and advanced breast cancer. Investigations at the level of tumor (epi)genome, pharmacogenomics and other omics technologies, immuno-oncology, or bioinformatic prediction tools are appreciated. Articles comprising basic science, clinical research, implementation or reviews are solicited that demonstrate how personalized medicine may improve outcomes of early (aggressive) or advanced breast cancer stages and help to avoid drug failure and toxicities.

Prof. Dr. Matthias Schwab
Dr. Werner Schroth
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.